Saturday, November 27, 2021
Home Tags Shilpa Medicare

Tag: Shilpa Medicare

Shilpa Medicare gets Import Alert from USFDA

Shilpa Medicare has received an import alert 66-40 on February 17, 2021, pursuant to the USFDA inspection of the Unit IV, Jadcherla,...

USFDA issues warning to Shilpa Medicare for cGMP violations

NEW DELHI: The US Food and Drug Administration (USFDA) has issued a warning letter to Shilpa Medicare for violating current good manufacturing practice norms...

USFDA issues warning letter to Shilpa Medicare, Telangana

Shilpa Medicare has received a warning letter through email from the USFDA for its Jadcherla facility, Telangana. The company...

Shilpa Medicare IBRUSHIL for treatment of leukaemia

Shilpa Medicare announced the launch of the Indian branded generic of lbrutinib, an anti-cancer drug under the brand name IBRUSHIL. Earlier it...

Shilpa Medicare gets EIR from USFDA

Shilpa Medicare Limited (SML) has announced the receipt of Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for...

Shilpa Medicare gets 15 observations from USFDA

Shilpa Medicare has received 15 observations from US Food and Drug Administration (FDA) for the company's finished dosage formulation facility (sterile...

Latest posts

High Court restrains publishing Ads in a dispute on Chyawanprash

The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video...

Authors

58 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS